?racial and ethnic differences in consumer reporting of adverse events (AE) associated with U.S. Food and drug administration (FDA) approved and compounded drug products in medwatch/FDA adverse…
Ended Awarded Last action
- Contract number
- 75F40123F19028
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $115,767
Award facts
- Opportunity
-
- FDARFTOP1265077 Solicitation number
- Contract value 100% obligated
- $115,767.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541820 Public Relations Agencies
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $115,767 |
About this award
This is a firm fixed-price BPA Call contract awarded by the Food and Drug Administration (FDA) to Westat, Inc., a prominent professional services firm. The contract is for a study on "Racial and Ethnic Differences in Consumer Reporting of Adverse Events (AE) Associated with U.S. Food and Drug Administration (FDA) Approved and Compounded Drug Products in MedWatch/FDA Adverse Event Reporting System (FAERS)." The contract has a ceiling value of $115,767.00 and a period of performance ending on August 31, 2025. This contract is not associated with a set-aside designation. Westat has been awarded several significant federal indefinite delivery vehicles (IDVs) across multiple agencies, enabling the company to provide flexible, long-term research and support services to federal agencies.
Description
?racial and ethnic differences in consumer reporting of adverse events (AE) associated with U.S. Food and drug administration (FDA) approved and compounded drug products in medwatch/FDA adverse event reporting system (faers) ?
Quick answers
Who was awarded contract 75F40123F19028?
75F40123F19028 was awarded to Westat, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 22, 2023.
How much is contract 75F40123F19028 worth?
The government has obligated $115,767 on 75F40123F19028.
Is contract 75F40123F19028 an order under another contract?
Yes. 75F40123F19028 is a BPA call under GS23F0155K-75F40120A00018, a blanket purchase agreement, on Advertising & Integrated Marketing Solutions (AIMS).
Was contract 75F40123F19028 competed?
The extent of competition for 75F40123F19028 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award